Glenmede Trust’s NutriSystem, Inc. NTRI Stock Holding History

Glenmede Trust’s Portfolio NTRI Stock Details NTRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-814	Closed	-$35	–	3256
2018 Q4	$35	Buy	+814	New	+$30.7K	﹤0.01%	1747
2018 Q2	–	Sell	-105	Closed	-$5K	–	2473
2018 Q1	$5K	Hold	105	–	–	﹤0.01%	2422
2017 Q4	$5K	Sell	105 -5,992	-98%	-$315K	﹤0.01%	2422
2017 Q3	$339K	Buy	6,097 +5,992	+5,707%	+$325K	﹤0.01%	1025
2017 Q2	$5K	Hold	105	–	–	﹤0.01%	2308
2017 Q1	$5K	Buy	+105	New	+$4.34K	﹤0.01%	2308
2016 Q2	–	Sell	-209	Closed	-$4K	–	2791
2016 Q1	$4K	Buy	209 +74	+55%	+$1.46K	﹤0.01%	2291
2015 Q4	$2K	Hold	135	–	–	﹤0.01%	2494
2015 Q3	$3K	Buy	135 +63	+88%	+$1.72K	﹤0.01%	2449
2015 Q2	$1K	Buy	+72	New	+$1.62K	﹤0.01%	2610

Other funds holding NTRI

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Glenmede Trust's NTRI Position: Q1 2019 in Review

Glenmede Trust sold out of NutriSystem, Inc. (NTRI) in Q1 2019, closing a stake of 814 shares — an estimated $35 sold.

Glenmede Trust first reported a position in NTRI in Q2 2015 and held it in 10 quarters. The position peaked at $339K in Q3 2017. 2 funds tracked by Wall St. Rank hold NTRI as of Q1 2019.

Glenmede Trust reported no remaining NutriSystem, Inc. position as of Q1 2019 after selling out during the quarter.
Glenmede Trust sold 814 NutriSystem, Inc. shares in Q1 2019, an estimated $35.
Glenmede Trust first reported a position in NutriSystem, Inc. in Q2 2015 and held it in 10 quarters.
Glenmede Trust's NutriSystem, Inc. position peaked at $339K in Q3 2017.
2 funds tracked by Wall St. Rank held NutriSystem, Inc. as of Q1 2019.

Based on Glenmede Trust's 13F filing for Q1 2019, filed 14 May 2019.